The impact of CSR on Pharmaceutical sector: Evidence from Incepta Pharmaceutical Company

Tapos Kumar


The purpose of this study is to investigate how CSR is practiced by Incepta Pharmaceutical Company. It considers how the concept has come to be framed within business in Pharmaceutical sector, which is increasingly globalized. The conversation is based on interviews with managers who address CSR issues and strategy and an analysis of posted reports consisting of annual reports of consecutive years. For this, an in-depth study through multiple methods, for example:  exploratory study, interview, were conducted to organize data. Findings show that Incepta Pharmaceutical mostly emphasizes on profitability aspects in comparison to other aspects. They want to wear a good corporate citizen, being ethical, obeying the law and being profitable. They define CSR such as what Incepta Pharmaceutical does, how they do it and the impact of their behavior on society at large.

Full Text:



Nippon Keidanren (Japan Business Federation). 2004. Basic Views on CSR Promotion (in Japanese).

Keizai Doyukai (Japan Association of Corporate Executives). 2004. CSR in Japanese Companies: Current Situations and Issues (in Japanese).

Nakamura, Y. 2008. Analysis of CSR. Newsweek (Japanese Edition), July 9: 77-78.

Kishimoto, Y., & Nakamura, Y. 2008. Analysis of Japanese Companies. Newsweek (Japanese Edition), July 9: 80-81.

David Crowther, Güler Aras(2008)-Corporate Social Responsibility.

Friedman, M. (1970). The social responsibility of business is to increase its profits. NY Times Magazine, 13 September, pp. 32-33, 122, 124, 126.


WBCSD (2004). Doing business with the poor: A field guide. Geneva: WBCSD.

Elkington, J. (1994). Towards the Sustainable Corporation: Win-Win-Win Strategies for Sustainable Development. California Management Review, 36[2], p. 90-100.

Castka, P., Bamber, C.J., Bamber, D.J. and Sharp, J.M. (2004b), “Integrating corporate socialresponsibility (CSR) into ISO management systems – in search of a feasible CSRmanagement system framework”,The TQM Magazine, Vol. 16 No. 3, pp. 216-24.

Sarbutts, N. (2003). Can SMEs “do” CSR? A practitioner’s view of the ways small-and medium-sized enterprises are able to manage reputation through corporate social responsibility. Journal of Communication Management, 7(4), 340-347.

Frederick, W. C. (1994). From CSR1 to CSR2 The Maturing of Business-and-Society Thought. Business & Society, 33(2), 150-164.

Windsor, D. (2001). The future of corporate social responsibility. International Journal of Organizational Analysis, 9(3), 225-256.

Carroll, A.B. (2004). Managing ethically with global stakeholders: A present and future challenge. Academy of management Executive, 18(2), 114-120.

Buhmann, K. (2006). Corporate social responsibility: What role for law? Some aspects of law and CSR. Corporate Governance: The international journal of business in society, 188-202.

Gerry Johnson, Kevan Scholes, Richard Whittington(2004), “Exploring Corporate Strategy: Text and Cases”

Incepta Pharmaceuticals, (2016), “Annual and Sustainable development report”, available at: http;//www. (accessed May 20, 2016).

Incepta Pharmaceuticals, (2015), “Annual and Sustainable development report”, available at: http;// (accessed May 20, 2016).

Incepta Pharmaceuticals, (2014), “Annual and Sustainable development report”, available at: http;// (accessed May 20, 2016).


  • There are currently no refbacks.

MAYFEB Journal of Business and Management
Toronto, Ontario, Canada
ISSN 2371-7742